The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact in delay of start of chemotherapy and surgery on pCR and survival in breast cancer: A pooled analysis of individual patient data from six prospectively randomized neoadjuvant trials.
 
Sibylle Loibl
No Relationships to Disclose
 
Gustavo Werutsky
No Relationships to Disclose
 
Valentina Nekljudova
No Relationships to Disclose
 
Sabine Seiler
No Relationships to Disclose
 
Jens Uwe Blohmer
No Relationships to Disclose
 
Carsten Denkert
No Relationships to Disclose
 
Claus Hanusch
Consulting or Advisory Role - Roche
 
Jens Bodo Huober
No Relationships to Disclose
 
Christian Jackisch
No Relationships to Disclose
 
Sherko Kummel
Honoraria - Amgen; Celgene; Genomic Health; Novartis; Roche
Consulting or Advisory Role - Roche
Research Funding - Roche
 
Andreas Schneeweiss
No Relationships to Disclose
 
Michael Untch
No Relationships to Disclose
 
Kerstin Rhiem
No Relationships to Disclose
 
Peter A. Fasching
Honoraria - Amgen; Novartis; Pfizer; Roche
Consulting or Advisory Role - Novartis; Pfizer; Roche
Research Funding - Amgen (Inst); Novartis (Inst)
 
Gunter Von Minckwitz
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Myriad Genetics (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Teva (Inst); Vifor Pharma (Inst)
 
Jenny Furlanetto
No Relationships to Disclose